PRNewsWire
13 Jul 2026, 08:40 UTC · 9w ago
Verdict
Headline takes no side. We score BMI −1.00 across three claims — strongly bearish.
−1.00strongly bearish
More negative than 95% of ticker scores this week
What the story claims
3 claims · scored −1 bearish … +1 bullish
ADMA Biologics is facing a securities class action lawsuit alleging the company 'stuffed the channel' to simulate sales activity.
More negative than 96% of claims this week
The lawsuit claims ADMA Biologics failed to disclose a related party transaction and made materially misleading public statements.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 3 movers · tap to explore
More negative than 86% of claims this week
The class period for the alleged securities violations spans from August 9, 2024, to March 25, 2026.
More negative than 66% of claims this week
Which stocks this story touches
More negative than 95% of ticker scores this week
The company is mentioned as being sued for securities law violations in a class action lawsuit.
More negative than 95% of ticker scores this week
The company is facing a class action lawsuit alleging securities law violations, false statements, and channel stuffing.
More negative than 95% of ticker scores this week
The company is mentioned as being sued for securities law violations in a class action lawsuit.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
PRNewsWire
2h ago
−12.0%
Price agrees with the score
$126.91 vs $144.18 close before publication (Jul 10) · not market-adjusted
BMI chart →
